Users, markets and psychoactive substances: recent developments (2018-2019)



Tendances n° 136, OFDT, 8 p.
December 2019

Since 1999, the Emerging Trends and New Drugs (TREND) unit of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring emerging trends and phenomena in the field of drugs. It focuses on populations that mostly consume psychoactive substances and is based on qualitative data collected by the network of TREND sites located in eight metropolitan areas.

The developments observed in 2018 confirm those highlighted in previous years. With regard to users, the living conditions of the most marginalised are deteriorating, as observed cyclically, especially in the case of young people and/or migrants. Some networks are rationalising their activities by adopting the organisational methods of traditional companies: marketing strategies, reducing stock, making the workforce more flexible, etc. At the same time, the diversity of available products is steadily rising and consumption of substances previously confined to certain environments (ketamine, GHB-GBL, nitrous oxide) is expanding.

Authors : Clément Gérome, Agnès Cadet-Taïrou, Michel Gandilhon, Maitena Milhet, Victor Detrez, Magali Martinez

Download the PDF file (538 Ko)








Drugs in Europe

2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.